In 2023 alone, approximately 297,790 women and 2,800 men will be diagnosed with breast cancer, and it’s estimated that up to 30 percent of patients will develop metastatic disease.
That’s why Spotlight on Metastatic Breast Cancer takes an in-depth look at the driving forces and innovations behind the latest diagnostic and treatment advances, featuring expert insights from leading clinicians and researchers dedicated to the fight against this disease.
Approaches to Utilizing Bone-targeting Therapies in mBC
The Role of PARP Inhibitors in Metastatic Breast Cancer
Diving into the Efficacy & Tolerability of mBC Treatment
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Evaluating Landmark Clinical Data for HER2-low Breast Cancer